Lucosky Brookman Client Conversion Labs Closes Initial Round Of $16 Million Private Placement
Lucosky Brookman represented its client, Conversion Labs, Inc., a direct-to-consumer telemedicine and wellness company, in connection with a $16 Million private placement with institutional investors. BTIG, LLC acted as exclusive placement agent for the offering.
“This new funding by institutional investors represents a tremendous affirmation of our business strategy and growth prospects,” stated Conversion Labs CEO, Justin Schreiber. “It also helps to satisfy the capital requirements for our NASDAQ listing application. As the leading securities exchange for emerging growth stocks, we expect a NASDAQ listing to increase our corporate visibility and broaden awareness of our success in the financial community.”
Mr. Schreiber commented, “We are very excited to have closed this offering in expedited fashion and would like to thank our securities counsel in Lucosky Brookman whose leadership and strategic guidance has been an integral part of the Company now standing on the precipice of listing on a national exchange.”
The company intends to use the net proceeds to expedite certain growth initiatives, including new customer acquisition, the development, and launch of new product lines, as well as for general corporate purposes.